Individualization in the management of fungal disease in the transplant recipient
Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections
Tuberculosis in renal transplant recipients
Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantation
Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation
Infections associated with ventricular assist devices
Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation
Dual infection with polyomavirus BK and acyclovir-resistant herpes simplex virus successfully treated with cidofovir in a bone marrow transplant recipient
Donor-transmitted toxoplasmosis in liver transplant recipients
Ethmoidal sinusitis caused by Exserohilum rostratum in a patient with malignant lymphoma after non-myeloablative allogeneic peripheral blood stem cell transplantation
The onset of rapidly progressive neurologic deterioration after a brief gastrointestinal illness in a renal allograft recipient
Two cases of hepatic zygomycosis in allogeneic stem cell transplant recipients and review of literature
Coccidioidomycosis masked by symptoms of end-stage liver disease in transplant candidates
Successful treatment of disseminated fusariosis with posaconazole during neutropenia and subsequent allogeneic hematopoietic stem cell transplantation
Outcomes of invasive zygomycosis infections in renal transplant recipients
Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON®-CMV
Lack of vision, loss of sight